CMS Proposes To Cover CT Lung Cancer Screening, With Lengthy Criteria
This article was originally published in The Gray Sheet
Executive Summary
CMS proposed Nov. 10 to for the first time cover for lung cancer screening with low dose computed tomography in a decision applauded by imaging and lung cancer groups. The proposed decision memo includes detailed eligibility criteria for coverage including mandatory registry data collection, required patient counseling visits and provider and facility accreditation standards.
You may also be interested in...
Medicare Covers CT Lung Cancer Screening With Tweaks From Proposal
CMS issued a final decision to cover annual low-dose computed tomography (LDCT) screening scans for Medicare patients who are asymptomatic but at high risk for lung cancer, and also made several changes from the proposed NCD in patient eligibility, and registry requirements, in an action praised by the imaging industry.
Medicare Advisors Doubt Benefits Of Low-Dose CT For Lung Cancer Screening
A Medicare advisory panel voted “low confidence” on the benefits of low-dose computed tomography for lung cancer screening at an April 30 meeting in Baltimore, Md.
CT Lung Cancer Screening Is Up For National Medicare Coverage Consideration
CMS agency accepted two formal requests to open a national coverage analysis for low-dose computed tomography as a lung-cancer screening tool for high-risk, but asymptomatic individuals, and plans to hold a MedCAC meeting on the topic in April.